This article provides a comprehensive resource for researchers and drug development professionals on the directed evolution of biosynthetic enzymes.
This article provides a comprehensive analysis of product inhibition, a fundamental regulatory mechanism in enzymatic biosynthesis where the end product negatively feedback-inhibits its own synthesis, limiting metabolic yield.
This article provides a comprehensive overview of contemporary strategies for optimizing enzyme activity and substrate specificity, addressing critical needs in biomedical research and drug development.
This article explores the paradigm shift in chemical synthesis driven by high-throughput experimentation (HTE) and automation.
Foundation models, large-scale AI systems pre-trained on vast datasets, are revolutionizing materials science and drug development.
This article provides a comprehensive analysis of Ribosomally synthesized and post-translationally modified peptides (RiPPs) as versatile platforms for peptide engineering.
This article explores the emerging frontier of biocompatible chemistry for plastic waste upcycling, a field that strategically merges synthetic and biological catalysis.
This article provides a comprehensive overview of the computational tools and methodologies revolutionizing the design and optimization of biosynthetic pathways for drug development.
This article explores computational retrosynthetic analysis for designing biosynthetic pathways to produce valuable natural products and therapeutics.
This article provides a comprehensive overview of modern strategies for engineering enzyme thermal stability, a critical property for industrial and pharmaceutical biocatalysis.